
N+1 et al. sell Xanit Group to Vithas
Funds managed by N+1, Partners Group and Akina have sold Spanish hospital group Xanit to local trade buyer Vithas.
Latest News
Quadrivio plans first close for EUR 500m Lifestyle Fund II by mid-2023
Italy-based GP will expand predecessor Made in Italy vehicle’s focus beyond Italy to target European SMEs
AnaCap reaps 4.3x on MRH Trowe minority stake sale to TA Associates
German insurance broker will now be backed by both GPs; deal comes 2.5 years into AnaCap's investment period
Bregal poaches Carlyle exec for new chief investment officer role
Ryan Selwood’s appointment follows other recent senior hires, including a chief people officer and a chief technology officer
Cinven’s indicative EUR 10 per share Synlab bid seen as below fair value
Sponsor listed the laboratory testing service provider at EUR 18 per share in 2020
Back to Top